These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 4200593)

  • 21. Comparison of antibody production against aflatoxin B1 in goats and rabbits.
    Gaur PK; El-Nakib O; Chu FS
    Appl Environ Microbiol; 1980 Sep; 40(3):678-80. PubMed ID: 7425620
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of biofilm formation in Pseudomonas aeruginosa by antisense mazE-PNA.
    Valadbeigi H; Sadeghifard N; Salehi MB
    Microb Pathog; 2017 Mar; 104():28-31. PubMed ID: 28062294
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Survival of Pseudomonas aeruginosa in the peritoneal cavity of mice treated with antilymphocyte serum.
    Grogan JB
    Arch Surg; 1972 Sep; 105(3):460-3. PubMed ID: 4626868
    [No Abstract]   [Full Text] [Related]  

  • 24. Development of antibody to each component of Clostridium botulinum type E progenitor toxin.
    Sakaguchi G; Sakaguchi S
    Jpn J Med Sci Biol; 1973 Dec; 26(5):187-95. PubMed ID: 4601357
    [No Abstract]   [Full Text] [Related]  

  • 25. Extracellular toxins of Pseudomonas aeruginosa.
    Liu PV
    J Infect Dis; 1974 Nov; 130 Suppl(0):S94-9. PubMed ID: 4370620
    [No Abstract]   [Full Text] [Related]  

  • 26. THE PYROGENIC EFFECT OF SCARLET FEVER TOXIN. I. NEUTRALIZATION WITH ANTITOXIN; THE NATURE OF TOLERANCE.
    SCHUH V
    Folia Microbiol (Praha); 1965 May; 10():156-62. PubMed ID: 14344773
    [No Abstract]   [Full Text] [Related]  

  • 27. Passive protective properties of serum fractions from mice inoculated with an anti-pseudomonas vaccine.
    Jones RJ; Hall M; Ricketts CR
    Immunology; 1972 Dec; 23(6):889-95. PubMed ID: 4630781
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Double gel diffusion studies on Pseudomonas aeruginosa O antigens.
    Lányi B; Adám MM
    Acta Microbiol Acad Sci Hung; 1973; 20(4):337-46. PubMed ID: 4211937
    [No Abstract]   [Full Text] [Related]  

  • 29. [Inhibition of generalization of wound infection in immunized rats].
    Pal'tsyn AA; Grishina IA; Kolokol'chikova EG; Chervonskaia NV; Badikova AK; Popova EP
    Biull Eksp Biol Med; 1994 May; 117(5):545-6. PubMed ID: 9296716
    [No Abstract]   [Full Text] [Related]  

  • 30. Recent investigations on Pseudomonas aeruginosa.
    Homma JY
    Jpn J Exp Med; 1971 Oct; 41(5):387-400. PubMed ID: 5002617
    [No Abstract]   [Full Text] [Related]  

  • 31. [The determination of specific Pseudomonas aeruginosa antitoxins in commercial preparations of human immunoglobulin].
    Vaneeva NP; Ianishevskaia MN; Aleksandrova TN; Ianshina NL
    Zh Mikrobiol Epidemiol Immunobiol; 1995; (1):59-61. PubMed ID: 7778378
    [TBL] [Abstract][Full Text] [Related]  

  • 32. AGGLUTINATING, LETHAL TOXIN AND E1 TOR HAEMOLYSIN NEUTRALIZING POTENCY OF SERA IN CHOLERA.
    FELSENFELD O; NASUNIYA N; WATANABE Y; PENA A; DALE BN
    Bull World Health Organ; 1964; 30(6):833-44. PubMed ID: 14215189
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clostridium oedematiens antitoxin: the correlation between anti-lethal and anti-edematizing activities.
    Izumi N; Tokumaru Y; Kondo H
    Jpn J Med Sci Biol; 1983 Apr; 36(2):75-83. PubMed ID: 6887628
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Obtaining the homologous hyperimmune preparations from the blood of immunized donors - anti-coli (anti-Escherichia) and antitoxic antipyocyanotic plasma].
    Skurkovich SV; Likhoded VG; Krokhina MA; Temper RM; Demidova NV
    Probl Gematol Pereliv Krovi; 1978 Feb; 23(2):51-3. PubMed ID: 417340
    [No Abstract]   [Full Text] [Related]  

  • 35. [On antitoxin immunization in horses].
    OBAYASHI S; TANAKA Y; UEMATSU N
    Nihon Saikingaku Zasshi; 1961 Apr; 16():354-8. PubMed ID: 13730141
    [No Abstract]   [Full Text] [Related]  

  • 36. Virulence and the role of iron in Pseudomonas aeruginosa infection.
    Bullen JJ; Ward CG; Wallis SN
    Infect Immun; 1974 Sep; 10(3):443-50. PubMed ID: 4214769
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Production of antibody against Pseudomonas aeruginosa and its serological typing.
    Homma JY; Shionoya H; Yamada H; Kawabe Y
    Jpn J Exp Med; 1971 Feb; 41(1):89-94. PubMed ID: 4994227
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of neonatal injection of normal horse serum on the elimination of horse antitoxin from the bloodstream of adult rabbits.
    GOWLAND G; OAKLEY CL
    J Pathol Bacteriol; 1963 Jan; 85():221-32. PubMed ID: 13949640
    [No Abstract]   [Full Text] [Related]  

  • 39. Serological typing of Pseudomonas aeruginosa.
    Madhubala ; Shriniwas
    Indian J Med Res; 1979 Jun; 69():926-32. PubMed ID: 112052
    [No Abstract]   [Full Text] [Related]  

  • 40. A live-attenuated Pseudomonas aeruginosa vaccine elicits outer membrane protein-specific active and passive protection against corneal infection.
    Zaidi TS; Priebe GP; Pier GB
    Infect Immun; 2006 Feb; 74(2):975-83. PubMed ID: 16428743
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.